Clinical Observation of Modified Yinqiaosan Combined with Antibiotics in Treatment of Acute Tonsillitis in Children with Wind-heat Invading Lung Syndrome
|更新时间:2023-04-28
|
Clinical Observation of Modified Yinqiaosan Combined with Antibiotics in Treatment of Acute Tonsillitis in Children with Wind-heat Invading Lung Syndrome
Chinese Journal of Experimental Traditional Medical FormulaeVol. 29, Issue 11, Pages: 121-125(2023)
QIAO Jinghua,YU Linlin,JING Xiaoping,et al.Clinical Observation of Modified Yinqiaosan Combined with Antibiotics in Treatment of Acute Tonsillitis in Children with Wind-heat Invading Lung Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(11):121-125.
QIAO Jinghua,YU Linlin,JING Xiaoping,et al.Clinical Observation of Modified Yinqiaosan Combined with Antibiotics in Treatment of Acute Tonsillitis in Children with Wind-heat Invading Lung Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(11):121-125. DOI: 10.13422/j.cnki.syfjx.20230125.
Clinical Observation of Modified Yinqiaosan Combined with Antibiotics in Treatment of Acute Tonsillitis in Children with Wind-heat Invading Lung Syndrome
To observe the clinical effect of modified Yinqiaosan combined with antibiotics in the treatment of acute tonsillitis in children with wind-heat invading lung syndrome.
Method
2
A total of 96 children with acute tonsillitis of wind-heat invading the lung syndrome were randomized into control group and observation group. The control group was treated with routine antibiotics, and the observation group was treated with modified Yinqiaosan and antibiotics for 7 days. The scores of major symptoms (sore throat, erythmatous throat, dysphagia, erythmatous tonsils and suppuration) and minor symptoms (fever, cough, stool, and tongue) and the levels of inflammation- and immune-related indexes [white blood cell (WBC), C-reactive protein (CRP), serum amyloid A (SAA), interleukin-6 (IL-6), and interferon-
γ
(IFN-
γ
)] were compared between two groups.
Result
2
The data of 92 children were statistically analyzed: 45 in the observation group and 47 cases in the control group. The total clinical effective rate of the observation group was 95.56%, as compared with the 93.62% of the control group. After treatment, the scores of major symptoms in the observation group were lower than those in the control group (
P
<
0.05), and the scores of cough, defecation, and tongue in the observation group were lower than those in the control group (
P
<
0.05). The levels of inflammation- and immune-related indexes after treatment in the observation group were lower than those before treatment (
P
<
0.05). Except IFN-
γ
, the levels of the inflammation- and immune-related indexes in the control group were lower than those before treatment (
P
<
0.05). After treatment, the levels of SAA and IL-6 in the observation group were lower than those in the control group (
P
<
0.05).
Conclusion
2
Modified Yinqiaosan combined with antibiotics can significantly reduce the expression of SAA and IL-6 in the treatment of children with acute tonsillitis, thereby alleviating inflammation and clinical symptoms and improving prognosis.
关键词
急性扁桃体炎乳蛾风热犯肺证银翘散加味儿童
Keywords
acute tonsillitistonsillitissyndrome of wind-heat invading lungmodified Yinqiaosanchildren
A Multicenter Clinical Trial of Pudilan Anti-inflammatory Oral Liquid of Different Doses in Treatment of Acute Pharyngitis/Tonsillitis Caused by Bacterial Infection in Adults
Clinical Efficacy of Huangqin Beimutang in Treatment of Chronic Rhinosinusitis in Children
Effect of Maxing Shigantang and Supplemented Guominjian Decoction on Symptoms and Inflammatory Cytokine Levels in Induced Sputum of Children with Cough Variant Asthma
Clinical Evidence of Chinese Patent Medicines in Treatment of Respiratory Diseases in Children: A Scoping Review
Sequential Treatment with Syndrome Differentiation on Children's Refractory Nephrotic Syndrome with Yiqi Huayu Qingre Prescription
Related Author
LI Dinglei
CUI Yinghai
YU Xuefeng
PANG Min
ZHANG Wei
MA Zhanping
ZHANG Nianzhi
HUANG Tao
Related Institution
Jichuan Pharmaceutical Group Co.Ltd.
Liaoning Academy of Traditional Chinese Medicine(TCM),The Second Affiliated Hospital of Liaoning University of TCM